Evaluating the medical management of locally advanced and metastatic basal cell carcinoma: A single institutional retrospective analysis investigating efficacy, safety, and tolerability

Annika Belzer; Jolanta Pach; Ryland D Mortlock; James Clune; Kelly Olino; Mario Sznol; Aarti Bhatia; Barbara Burtness; Sean Christensen; Jonathan S Leventhal

doi:10.1016/j.jdin.2023.02.007

Evaluating the medical management of locally advanced and metastatic basal cell carcinoma: A single institutional retrospective analysis investigating efficacy, safety, and tolerability

JAAD Int. 2023 Feb 26:11:174-175. doi: 10.1016/j.jdin.2023.02.007. eCollection 2023 Jun.

Authors

Affiliations

¹ Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
² Department of Plastic Surgery, Yale School of Medicine, New Haven, Connecticut.
³ Department of Surgical Oncology, Yale School of Medicine, New Haven, Connecticut.
⁴ Department of Internal Medicine and Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.

No abstract available

Keywords: HPI; ICI; aBCC; advanced basal cell carcinoma; basal cell carcinoma; checkpoint inhibitor; cutaneous oncology; hedgehog pathway inhibitor; immunotherapy.

Grants and funding

UL1 TR001863/TR/NCATS NIH HHS/United States